Mdxhealth SA (MDXH) — 6-K Filings

All 6-K filings from Mdxhealth SA. Browse 26 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (26)

MDxHealth SA Files 6-K, Attaches Press Release — Nov 12, 2025 Risk: low
On November 12, 2025, MDxHealth SA issued a press release, attached as Exhibit 99.1 to this 6-K filing. The filing indicates that MDxHealth SA is a foreign priv
MDxHealth SA Files 6-K, Attaches Press Release — Sep 16, 2025 Risk: low
On September 15, 2025, MDxHealth SA issued a press release attached as Exhibit 99.1 to this 6-K filing. The filing does not contain specific financial figures o
MDxHealth SA Files 2025 Interim Report on Form 6-K — Aug 14, 2025 Risk: low
MDxHealth SA filed a Form 6-K on August 14, 2025, reporting its 2025 Interim Report. The report includes preliminary financial results and confirms the accuracy
MDxHealth SA Files Form 6-K with Press Release — Aug 5, 2025 Risk: low
On August 5, 2025, MDxHealth SA announced the issuance of a press release, attached as Exhibit 99.1 to this Form 6-K filing. The press release details informati
MDxHealth Appoints New Audit Committee Chair, Director Resigns — Jul 3, 2025 Risk: low
MDxHealth SA announced on July 3, 2024, that Michael Holder will join its Board of Directors as Chair of the Audit Committee, effective July 3, 2025. He will su
MDxHealth SA Holds Shareholder Meetings — Jun 6, 2025 Risk: low
MDxHealth SA held its ordinary annual general shareholders' meeting (AGM) and an extraordinary general shareholders' meeting (EGM) on May 28, 2025. The agenda i
MDxHealth SA Files 6-K, Incorporates Exhibits into F-3 — May 14, 2025 Risk: low
MDxHealth SA filed a Form 6-K on May 14, 2025, to report information as a foreign private issuer. The filing incorporates by reference Exhibit 99.1 into existin
MDxHealth SA Announces General Shareholders' Meeting — May 6, 2025 Risk: low
MDxHealth SA is holding its Ordinary and Extraordinary General Shareholders' Meetings on May 28, 2025, in Ghent, Belgium. The company is a foreign private issue
MDxHealth SA Schedules Shareholder Meeting for May 28 — May 2, 2025 Risk: low
MDxHealth SA is holding its Ordinary and Extraordinary General Shareholders' Meetings on May 28, 2025, in Ghent, Belgium. The company is a foreign private issue
MDxHealth CEO Buys 50,000 Shares — Mar 7, 2025 Risk: low
On March 6, 2025, MDxHealth SA (NASDAQ: MDXH) announced that its CEO, Michael McGarrity, purchased 50,000 shares of the company's stock. McGarrity is also a mem
MDxHealth SA Files 6-K, Attaches Press Release — Feb 26, 2025 Risk: low
On February 26, 2025, MDxHealth SA announced the issuance of a press release, attached as Exhibit 99.1 to this 6-K filing. The filing itself is a Report of Fore
MDxHealth SA Files 6-K, Announces Press Release — Jan 13, 2025 Risk: low
On January 13, 2025, MDxHealth SA announced the issuance of a press release, attached as Exhibit 99.1 to this Form 6-K filing. The filing itself does not contai
MDxHealth SA Files 6-K, Incorporates by Reference — Nov 6, 2024 Risk: low
MDxHealth SA filed a Form 6-K on November 6, 2024, for the month of November 2024. This report is for a foreign private issuer and is being incorporated by refe
MDxHealth SA Files 6-K, Incorporates Exhibit 3.1 — Oct 29, 2024 Risk: low
MDxHealth SA filed a Form 6-K on October 29, 2024, to incorporate by reference Exhibit 3.1 into its existing Form F-3 registration statement (Registration State
MDxHealth SA Files 6-K, Incorporates Exhibits into F-3 — Sep 30, 2024 Risk: low
MDxHealth SA filed a Form 6-K on September 30, 2024, reporting information for the month of September 2024. The filing incorporates by reference several exhibit
MDxHealth SA Files 6-K with Interim Report — Aug 21, 2024 Risk: low
MDxHealth SA filed a Form 6-K on August 21, 2024, reporting its 2024 Interim Report and a press release. The filing includes information for the month of August
MDxHealth SA Reports Preliminary Q2 2024 Revenue of $22.2M — Jul 8, 2024 Risk: medium
MDxHealth SA reported preliminary Q2 2024 revenues of approximately $22.2 million and first half 2024 revenues of $42.0 million on July 8, 2024. The company's c
MDxHealth SA Approves New Share Option Plan — Jun 20, 2024 Risk: low
MDxHealth SA held an extraordinary general shareholders' meeting on June 20, 2024, where they approved a new 2024 Share Option Plan and the issuance of 2,000,00
MDxHealth SA Holds Shareholder Meetings — Jun 5, 2024 Risk: low
MDxHealth SA held its ordinary annual general shareholders' meeting (AGM) and an extraordinary general shareholders' meeting (EGM) on May 30, 2024. The agenda i
MDxHealth SA Schedules May 30th Shareholder Meeting — May 16, 2024 Risk: low
MDxHealth SA is holding its Ordinary and Extraordinary General Shareholders' Meetings on May 30, 2024, in Ghent, Belgium. The company is a foreign private issue
MDxHealth CEO Buys 45,000 Shares — May 6, 2024 Risk: low
On May 3, 2024, MDxHealth SA CEO Michael McGarrity purchased 45,000 shares of the company's common stock. This purchase was disclosed in a Form 6-K filing with
MDxHealth SA Secures New Credit Facility — May 1, 2024 Risk: medium
On May 1, 2024, MDxHealth SA entered into a Credit Agreement where it acts as guarantor for its wholly-owned subsidiary, MDxHealth, Inc. The filing does not spe
MDxHealth SA Files 6-K Report with Press Release — Mar 12, 2024 Risk: low
On March 12, 2024, MDxHealth SA announced the issuance of a press release, attached as Exhibit 99.1 to this Form 6-K filing. The press release details informati
MDxHealth SA Files 6-K Report for March 2024 — Mar 6, 2024 Risk: low
On March 6, 2024, MDxHealth SA announced the issuance of a press release, attached as Exhibit 99.1 to this 6-K filing. The press release details the company's a
MDxHealth SA Furnishes Press Release via 6-K Filing — Feb 16, 2024 Risk: low
MDxHealth SA, a foreign private issuer, filed a Form 6-K on February 16, 2024, to furnish a press release issued on the same date. The company, based in Herstal
MDxHealth Reports Preliminary Q4/FY23 Revenue, Issues 2024 Guidance — Jan 8, 2024
MDxHealth SA, a medical diagnostics company, filed a 6-K on January 8, 2024, to announce its preliminary fourth quarter and full year 2023 revenues and to provi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX